Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Caitlin E. Cox

June 14, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

L.A. McKeown

May 11, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Daily News

Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos

Caitlin E. Cox

November 17, 2016

News Daily News

Según los Investigadores, Contemplar de Embolismo Pulmonar por Síncope Inexplicado es ‘Absolutamente Obligatorio.’

Michael O'Riordan

October 24, 2016

News Daily News

Incluso Sin Prueba de Beneficio, 1 de cada 6 Pacientes Reciben Filtros de la Vena Cava

Yael L. Maxwell

February 29, 2016

Advertisement

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

November 2024 Dispatch for the CV Team

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

October 2023 News Roundup

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

October 2021 News Roundup

July/August 2021 News Roundup

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Study Affirms Thrombotic Risk in COVID-19

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

TCTMD’s Top 10 Most Popular Stories for August 2018

Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos

Según los Investigadores, Contemplar de Embolismo Pulmonar por Síncope Inexplicado es ‘Absolutamente Obligatorio.’

Incluso Sin Prueba de Beneficio, 1 de cada 6 Pacientes Reciben Filtros de la Vena Cava

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content